Gene · 7001
Papers3,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unveiling the Potential Binding Targets of Celastrol in Colorectal Cancer: A Proteomic Profiling Approach Integrating Cellular Thermal Shift Assay and Pulse Proteolysis. | J Proteome Res | 2025 | 40480957 | PubTator, text mining | PubMed |
| Preliminary Exploration of Paper-based ELISA with Recombinant Thioredoxin Peroxidase-1 for Detection of Human Schistosomiasis. | Acta Parasitol | 2025 | 40465094 | PubTator, text mining | PubMed |
| Proteome Profiling in Cerebrospinal Fluid Reveals Increased Levels of Peroxiredoxin 2 Discriminating Japanese Encephalitis Virus and Scrub Typhus Infection. | J Med Virol | 2025 | 40457628 | PubTator, text mining | PubMed |
Oxidative stress markers and tissue iron overload after 12-months vitamin E supplementation for children with transfusion-dependent β-thalassemia on different iron chelators: A randomized placebo-controlled trial. | Clin Nutr | 2025 | 40424814 | PubTator, text mining | PubMed |
| Correction: CircDIDO1 inhibits gastric cancer progression by encoding a novel DIDO1‑529aa protein and regulating PRDX2 protein stability. | Mol Cancer | 2025 | 40394652 | PubTator, text mining | PubMed |
| Salvianolic acid B exerts cerebroprotective effects after traumatic brain injury via Nrf2-dependent antioxidant and anti-inflammatory cascades. | Exp Neurol | 2025 | 40383364 | PubTator, text mining | PubMed |
| Rpl13a snoRNAs U34 and U35a: New Targets for Sickle Cell Disease Complications. | Circ Res | 2025 | 40371475 | PubTator, text mining | PubMed |
| Vitreous proteomics in rhegmatogenous retinal detachment and proliferative vitreoretinopathy. | Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub | 2025 | 40371444 | PubTator, text mining | PubMed |
| Applications of the Cellular Thermal Shift Assay to Drug Discovery in Natural Products: A Review. | Int J Mol Sci | 2025 | 40362180 | PubTator, text mining | PubMed |
| Serum peroxiredoxin 2 emerges as a predictive biomarker of poor neurological outcome and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a prospective cohort study. | Neurosurg Rev | 2025 | 40347370 | PubTator, text mining | PubMed |
| Integrated synchrotron radiation-based fourier transform infrared (SR-FTIR) microscopy and tandem-mass spectrometry (LC-MS/MS) used to elucidate the apoptotic effect of chamuangone in A549 cells. | Biochem Biophys Res Commun | 2025 | 40252398 | PubTator, text mining | PubMed |
| Mechanism of glutathionylation of the active site thiols of peroxiredoxin 2. | J Biol Chem | 2025 | 40220998 | PubTator, text mining | PubMed |
| Tyrosine kinase inhibitors modulate the expression of peroxiredoxins 1 and 2 in chronic myeloid leukemia cells. | Leuk Res Rep | 2025 | 40206283 | PubTator, text mining | PubMed |
| Endothelial USP11 drives VEGFR2 signaling and angiogenesis via PRDX2/c-MYC axis. | Angiogenesis | 2025 | 40199774 | PubTator, text mining | PubMed |
| Expression and mechanism of PRDXs family in oral squamous cell carcinoma. | Discov Oncol | 2025 | 40153088 | PubTator, text mining | PubMed |
Feasibility of Serum Peroxiredoxin 2 as a Biochemical Indicator for Reflecting Severity and Prognosticating Stroke-Associated Pneumonia, Early Neurological Deterioration and Poor Neurological Outcomes in Acute Supratentorial Intracerebral Hemorrhage: An Observational Analytical Clinical Study. | Neuropsychiatr Dis Treat | 2025 | 40134763 | PubTator, text mining | PubMed |
| The rheumatoid arthritis drug Auranofin targets peroxiredoxin 1 and peroxiredoxin 2 to trigger ROS-endoplasmic reticulum stress axis-mediated cell death and cytoprotective autophagy. | Free Radic Biol Med | 2025 | 40089079 | PubTator, text mining | PubMed |
| Mitapivat metabolically reprograms human β-thalassemic erythroblasts, increasing their responsiveness to oxidation. | Blood Adv | 2025 | 40085946 | PubTator, text mining | PubMed |
| Unraveling the multifaceted roles of peroxiredoxins in sickle cell anemia: implications in redox and inflammation adaptations. | Ann Hematol | 2025 | 40085210 | PubTator, text mining | PubMed |
| On the road: extracellular vesicles in intercellular communication. | Cell Commun Signal | 2025 | 39966900 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7001/papers?page=6